Etodolac 400 MG Oral Tablet

INDICATIONS AND USAGE Carefully consider the potential benefits and risks of etodolac and other treatment options before deciding to use etodolac. Use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see WARNINGS ). Etodolac is indicated: For acute and long-term use in the management of signs and symptoms of the following: Osteoarthritis Rheumatoid arthritis For the management of acute pain

stat rx usa llc

FDA Reported Adverse Reactions
`[1] drug ineffective` `[2] fatigue` `[3] pain` `[4] dyspnoea` `[5] off label use` `[6] headache` `[7] nausea` `[8] rash` `[9] arthralgia` `[10] diarrhoea`

5 years ago

OVAL WHITE APO 041 400

5 years ago

APO 041 400 OVAL WHITE

HOW SUPPLIED Etodolac Tablets USP are available as: 400 mg tablets (white to off-white, oval, unscored, film-coated tablets, imprinted "APO 041" on one side and "400" on the other side.) - in bottles of 30, NDC 42549-511-30 - in bottles of 60, NDC 42549-511-60 Store at 20° to 25°C (68° to 77°F); excursions permitted to 15°C to 30° (59° to 86°F) [see USP Controlled Room Temperature]. Dispense in a tight, light-resistant container [see USP]. APOTEX INC. ETODOLAC TABLETS USP 400 mg and 500 mg Manufactured by: Manufactured for: Apotex Inc. Apotex Corp. Toronto, Ontario Weston, Florida Canada M9L 1T9 33326 Revised: January 2006 Rev. 2 Relabeling and Repackaging by : STAT Rx USA LLC Gainesville, GA 30501

More pills like OVAL APO 041 400

Related Pills

etodolac 400 MG Oral Tablet

Apotex Corp.

DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site